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Abstract
Background and objective Clinical characteristics of human
bocavirus (HBoV) infection have been studied worldwide,
but their importance of those characteristics remains
unknown. We investigated distinctive clinical features of
HBoV-positive children with lower respiratory tract infec-
tion (LRTI).
Methods and results During April 2007–July 2009, for 402
hospitalized children younger than 2 years with LRTI, we
prospectively examined virus genomes in nasopharyngeal
swabs for HBoV, respiratory syncytial virus (RSV), rhinovi-
rus, metapneumovirus, parainfluenzavirus, and adenovirus.
The HBoV genomes were identified in 34 patients (8.5%).
Clinical and laboratory data of HBoV-positive and other
virus/bacteria-negative patients (n=18) were analyzed and
compared with data of RSV-single positive patients (n=99).
The seasonal distribution of HBoV exhibits a concentration
of cases during March–September, with most RSV cases
occurring during winter in Japan. The minimum age of
HBoV-positive patients was 5 months, although 44 patients
(44%) with RSV were younger than 6 months. The main
clinical features were respiratory distress and hypoxia.
Hypoxia advances within 3 days after onset. The mean
oxygen saturation on arrival was 92.8%, which was
significantly lower than that in patients with RSV (p<
0.001). White blood cell counts were similar among groups.
However, the percentage of neutrophils in white blood cells
were significantly higher in HBoV-positive patients (62 vs.
45%, p<0.001). Their prognoses were good. Their hospital
stays were 6.6 days.
Conclusions HBoV-single positive patients show several
clinical characteristics, such as seasonality, age, hypoxia,
and neutrophilia, which differ from those with RSV
infection.
Keywords Human bocavirus.Respiratory syncytial virus.
Lower respiratory tract infection.Infant
Pneumonia and other lower respiratory tract infections
(LRTIs) are a major cause of mortality and morbidity in
infants and young children [6]. During the past decade,
detection of various respiratory viruses has improved by
virtue of new molecular techniques and the availability of
monoclonal antibodies for many viral species. New viruses
such as human metapneumovirus (hMPV) [28], severe
acute respiratory syndrome coronavirus (SARS-CoV) [11,
16, 23], and human bocavirus (HBoV) are reportedly major
pathogens of human respiratory infection.
SincethedetectionofHBoVfromrespiratorytractsamples
from Swedish infants and children with LRTI [3], reports
related to HBoV have been published around the world.
Epidemiological data show that HBoV is present on every
continent with different incidence rates and seasonality. In
fact, HBoV is detected year round, with rates of 0.5–19% in
patients with LRTI [2, 7, 13, 15, 26]. Recently, this virus is
propagated in an in vitro culture system [10]. No animal
model of infection has been established. Nevertheless, the
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DOI 10.1007/s00431-010-1183-xfact that HBoV is not detected randomly in materials but is
detected significantly more often in the absence of other
viruses suggests that HBoVis a causative agent of previously
unexplained respiratory tract infections [25].
Several epidemiological and clinical investigations have
assessed HBoV-related illness; its clinical features have
been reported as resembling those of respiratory syncytial
virus (RSV) and human metapneumovirus (hMPV) infec-
tions [5]. Nevertheless, few data are available related to
physical characteristics and clinical severity for children
with HBoV-positive LRTIs [19]. To determine precise
clinical characteristics in HBoV-positive patients, we
prospectively collected numeric data for the clinical status
of young children with LRTI and analyzed them. Results
showed several unique physical characteristics in HBoV-
positive patients that differed significantly from those in
RSV-positive patients.
Patients and methods
Patients
The study population comprised 402 children younger than
2 years who were hospitalized with lower respiratory tract
disease at some time during March 2007–July 2008 (248
male, mean age 11.6 months ± standard deviation 6.5).
Informed consent was obtained from parents or guardians.
Of the patients, 93 (23.2%) were younger than 6 months.
This study was approved by the Ethical Committee of
Tokyo Women’s Medical University (#1492).
On admission, the medical history and physical character-
istics of the children were recorded systematically. For this
study, LRTI was defined as the presence of wheezing,
crackling rales, dyspnea, and/or obstruction of the airways,
with or without fever. All patients with suspected LRTI
underwent chest radiography. Pneumonia was defined as the
presence of focal infiltration or consolidation in the lung by
chest radiography. Blood samples were obtained to measure
quantities of whole white blood cells (WBCs) as well as
neutrocytes, lymphocytes, monocytes, and eosinophils. Se-
rum samples were obtained to measure C-reactive proteins.
Oxygen saturation of the children was monitored during
the hospital stay. Oxygen therapy was provided to achieve
oxygen saturation ≥95%. A physician judged the broncho-
dilator use and administration of antibiotics for each patient
according to physical findings and laboratory data.
Nucleic acid extraction and amplification
A nasopharyngeal swab was collected from each patient
and then dipped into saline and stored at −80°C until
nucleic acid extraction. Nucleic acid was extracted using a
kit (High Pure Viral Nucleic Acid Kit; Roche Diagnostics
Corp., Mannheim, Germany) according to the manufac-
turer’s recommended procedures. Then PCR/reverse-tran-
scription PCR (RT-PCR) was performed using previously
described methods with slight modifications [1, 3, 4, 9, 22,
24]. Briefly, for the RNAviruses, a superscript one-step RT-
PCR system (Invitrogen Corp., Carlsbad, CA, USA) was
used for reverse-transcription and first-round PCR with
virus specific primers under the manufacturer’s instructions.
For DNA viruses and also nested PCR, Ex Taq DNA
polymerase (Takara Bio Inc., Shiga, Japan) was used along
with the manufacturer’s supplied buffer under the appro-
priate thermal cycle conditions for each primer. Each
sample was examined for RSV, rhinovirus (RV), hMPV,
HBoV, adenovirus (AdV), and parainfluenzavirus (PIV).
Following amplification, PCR products were separated on
the 1.5% agarose gel with Tris–boric acid–EDTA buffer
and visualized with SYBR-green (Cambrex Corp., Rock-
land, ME, USA) under a UV transilluminator. The PCR
products were purified; their nucleic acid sequences were
determined to confirm PCR results. Nucleotide sequences
were processed using software (GENETYX) and compared
to nucleotide sequences of the DNA database using a
BLAST system [20].
Statistical analysis
All data were described as mean (m) ± standard deviation
(SD). Parametric data were analyzed using Student’s t-test.
A p value of <0.05 was considered statistically significant.
All analyses were performed using software (JMP ver.8;
SAS Institute Inc., NC, USA).
Results
Frequency and seasonality of human bocavirus detection
Table 1 presents infectious agents detected in the study
population. We detected at least one virus agent in 226
(56.2%) of the 402 children; 36 patients (9.0%) were co-
infected with different viruses. No virus was detected in
140 patients (34.8%).
During the same study period, we prospectively collect-
ed swabs from 30 age-matched children with no respiratory
symptoms and analyzed them similarly. Except for one
patient, who was positive for rhinovirus, no virus was
detected in these 30 children.
In hospitalized infants and young children aged 0–
24 months, RSV was the most commonly detected virus. Of
402 patients, 111 were RSV-positive (27.6%). In 99 out of
111 patients with RSV, PCR results for other viruses were
negative. Bocavirus was the fourth most common virus in
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(8.5%) were HBoV positive. In 14 of 34 patients (41%),
some other virus and HBoV were double positive (five with
PIV, four with rhinovirus, two with hMPV, two with AdV,
and one with RSV). In the other 20 patients (59%), PCR
results for other viruses were negative. Of the 20 patients,
two showed co-infection with Streptococcus pneumoniae,
as diagnosed from sputum culture. We specifically exam-
ined the other 18 patients for the analysis of clinical
features associated with HBoV infection.
Seasonal distribution of HBoV was noted during March–
September (Fig. 1a). During March–May 2008, HBoV-
positive patients accounted for 37% of all hospitalized
children with LRTIs, suggesting that HBoV is a common
etiologic agent causing LRTIs during spring and early
summer in the area of Tokyo, Japan (35°N).
Clinical manifestations of LRTI patients positive for human
bocavirus
The median age of HBoV-positive and other virus/bacteria-
negative patients (n=18) was 14 months. The minimum age
was 5 months (Fig. 2a); this patient was the only one under
6 months of age who had HBoV. Four patients had
underlying diseases. One had Down syndrome, with
congenital heart disease and pulmonary hypertension. The
other two patients had chronic respiratory conditions: one
was an extremely low birth weight infant developing
chronic lung disease and the other with bronchial asthma.
The last patient had mental retardation.
Of 18 patients, seven (39%) were diagnosed with acute
pneumonia. Chest X-rays of seven patients showed retic-
ulonodular infiltrates in one or several segments. Two
patients had lobar atelectasis. The other 11 patients were
diagnosed with acute bronchitis (Table 2).
The most common symptoms of HBoV-positive patients
were cough and fever, which were found in all 18 patients
(100%). High fever over 38.5°C was found in 13 patients
(72%). The mean maximum temperature was 38.9±0.8°C.
Wheezing and respiratory distress were found in 14 patients
(78%). One patient had diarrhea; the other 17 patients had
no gastrointestinal manifestation.
Hypoxia was a characteristic feature in HBoV-positive
patients (Table 2). On admission, the mean oxygen
Number Percent
Patients infected with a single pathogen 226 56.2%
RSV 99 24.6%
RV 41 10.2%
hMPV 37 9.2%
HBoV 20 5.0%
PIV 15 3.7%
AdV 14 3.5%
Patients infected with more than one pathogen 36 9.0%
HBoV+PIV 5 1.2%
HBoV+RV 4 1.0%
HBoV+HMPV 2 0.5%
HBoV+AdV 2 0.5%
HBoV+RSV 1 0.2%
RSV+RV 6 1.5%
RSV+AdV 3 0.7%
PIV+RV 2 0.5%
hMPV+AdV 3 0.7%
hMPV+RV 2 0.5%
hMPV+RSV 1 0.2%
hMPV+PIV 1 0.2%
AdV+RV 1 0.2%
AdV+PIV 1 0.2%
AdV+hMPV+RV 1 0.2%
RSV+AdV+RV 1 0.2%
Patients not infected with any studied pathogen 140 34.8%
Total 402 100%
Table 1 Viruses detected in 402
patients under 2 years of age
with lower respiratory tract
infection
RSV respiratory syncytial virus,
RV rhinovirus, hMPV human
metapneumovirus, HBoV human
bocavirus, PIV parainfluenza
virus, AdV adenovirus
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mean period from onset of illness to admission was 3.0±
1.1 days. For 17 of 18 patients, the main reason for
admission was hypoxia and/or respiratory distress. Actual-
ly, 14 patients (78%) needed oxygen therapy. No patient
required mechanical ventilation.
The clinical course was good except for that of one
infant, who had extremely low birth weight and had chronic
lung disease. The length of the hospital stay was 6.6±
3.2 days.
Comparison of clinical data of patients positive for HBoV
with those of patients positive for RSV
We compared clinical data of the 18 patients with the data
of hospitalized patients who were positive for RSV and
negative for other viruses in the same study period (n=99,
Table 2).
A seasonal distribution of HBoV was noted during
March–September. However, RSV was identified all year
round; its epidemic peak was November–December
(Fig. 1b). Age distributions of the two groups differed.
One patient had HBoV at less than 6 months of age,
although 44 patients with RSV (44%) were less than
6 months of age (Fig. 2b).
The period from disease onset to admission was
significantly shorter among HBoV-positive patients than
Fig. 2 a Age (months) of patients with detected HBoV. b Age
(months) of patients with detection of RSV
Fig. 1 a Distribution of human HBoV-positive cases by month.
b Distribution of RSV-positive cases by month
Table 2 Clinical data in children positive with HBoV and in children
positive with RSV
HBoV RSV p value
n=18 n=99
Age (months) 14.1±5.1 8.9±7.0 0.0008
Gender (male %) 78 81 NS
Diagnosis (pneumonia %) 39 34 NS
Day on admission 3.0±1.1 4.0±1.4 0.008
Oxygen saturation (%) 92.8±4.8 95.7±2.9 0.0004
Highest temperature (°C) 38.9±0.8 38.7±1.8 NS
WBC (×10
3 cells/mm
3) 11.4±2.9 11.4±4.6 NS
Neutrophils (%) 62±15 45±18 <0.0001
CRP (mg/dL) 2.62±2.55 1.96±2.95 NS
Days in hospital (days) 6.6±3.2 6.3±1.8 NS
CRP C-reactive protein, NS not significant, WBC white blood cell
1090 Eur J Pediatr (2010) 169:1087–1092among RSV-positive patients (p=0.008, Table 2). Further-
more, the mean oxygen saturation in HBoV-positive
patients on admission was significantly lower than that in
RSV-positive patients (p=0.0004, Table 2). White blood
cell (WBC) counts in these two groups were similar.
However, the percentage of neutrophils in WBCs were
significantly higher in HBoV-positive patients than in RSV-
positive patients (p<0.0001, Table 2). The C-reactive
protein in HBoV-positive patients was similar to that of
RSV-positive patients (Table 2).
The hospital stay lengths of the groups were similar. No
patient in either group required mechanical ventilation.
Discussion
This prospective study reveals several characteristics of
HBoV-positive LRTI in young children: seasonality, age
distribution, hypoxia, neutrophilia, and findings in chest
radiography. Comparison of clinical features to those in
patients with RSV infection, which is the major etiologic
agent in LRTI of young children, showed that major clinical
manifestations such as wheezing and respiratory distress
were similar in both groups of patients. However, several
physical characteristics of HBoV-positive patients differed
significantly from those of RSV-positive patients. To
describe clinical manifestations of children with LRTIs
with HBoV clearly, we selected HBoV-positive and other
virus/bacteria-negative patients.
Regarding the HBoV seasonality, its peak was similar to
that identified in a previous study in northern Japan. In the
study, HBoV-positive patients were most prevalent during
January–May. The peak occurred during April–May in
Japan [17]. The seasons are important diagnostic informa-
tion in Japan. In France, the seasonal distribution is
November–June; the peak occurs in March–April [15],
which resembles the circumstances in Japan. In Hong Kong
and Thailand, the peak seasons were in fall and winter,
respectively [8, 14].
Specific examination of extremely young patients
revealed a clear difference in the age distribution of
HBoV-positive patients from that of RSV. In RSV-positive
patients, 44% of all patients were younger than 6 months.
In contrast, the minimum age of HBoV-positive patients
was 5 months. Endo et al. measured the levels of the
antibody in human serum samples aged from 0 months to
41 years and reported that the seropositive rate was lowest
in the age group of 6–8 months [12]. These data suggest
that infants younger than 6 months might be protected from
HBoV infection.
The main clinical features in HBoV-positive patients are
respiratory distress and hypoxia, which are frequently
observed in LRTI patients with RSV. In our study, oxygen
saturation on admission shows that hypoxia was more
severe in HBoV-positive patients than in RSV-positive
patients. Moreover, the short duration from disease onset to
admission shows that respiratory distress and hypoxia
progress rapidly in HBoV-positive patients. Oikawa et al.
recently reported a severe case with HBoV associated with
plastic bronchitis, which necessitated mechanical ventila-
tion [21]. Many previous reports have not described severe
cases of HBoV infection; however, the sample size is small
and the studies were retrospective. In our study, one out of
18 patients had severe pneumonia and remained hospital-
ized for 19 days. A larger number of cases with HBoV-
positive LRTI must be accumulated to discuss the disease
severity. Patients with RSV infection sometimes need
intensive care. Pediatricians have specifically addressed
the care and protection of this infection. One reason is that
the RSV infection is frequently found in infants who are
younger than 3 months. Furthermore, patients younger than
3 months often require intensive care. In contrast, the
minimum age of HBoV-positive patient is 5 months in our
study. Therefore, the difference in the age of patients might
affect the disease severity.
Laboratory data show that the rate of neutrophils in
WBCs is significantly higher in HBoV-positive patients,
which is a unique characteristic of HBoV-positive LRTI. It
is particularly interesting that the rate of neutrophils in
hMPV-positive patients is similar to that in RSV-positive
patients (data not shown). This parameter might strongly
support clinical diagnosis of LRTI with HBoV. Acute
hypoxia induces a differential response in peripheral blood
neutrophils and lymphocytes, resulting in neutrophilia and
lymphopenia [27]. Hypoxia might be associated with
neutrophilia in HBoV-positive patients. However, the
precise mechanisms for neutrophilia remain unclear.
Recently, a high co-infection rate is under discussion in
HBoV-positive respiratory infection [17, 18]. Previous
reports have presented the possibility that HBoV detection
in respiratory tract samples reflects asymptomatic persis-
tence or prolonged viral shedding [26]. Although results of
the present study also show a high co-infection rate, clinical
characteristics in HBoV-single positive patients strongly
suggest the pathogenic potential of HBoV in young
children with LRTIs.
This study did not survey all respiratory viruses such as
coronavirus or influenza virus. Quantification of viral loads
might provide useful information, especially information
that would be useful to analyze co-infection cases more
clearly.
In conclusion, the results of our study support that
HBoV is an important causative agent in young children
hospitalized with LRTI in Japan. In young children, HBoV-
positive patients show several clinical characteristics that
differ from those with RSV. More cases should be
Eur J Pediatr (2010) 169:1087–1092 1091examined to confirm clinical manifestations and prognoses
of HBoV-associated LRTIs.
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